financetom
Business
financetom
/
Business
/
CompoSecure's Q3 Adjusted Net Income, Sales Rise; 2024 Net Sales Guidance Narrowed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CompoSecure's Q3 Adjusted Net Income, Sales Rise; 2024 Net Sales Guidance Narrowed
Nov 9, 2024 1:02 PM

07:43 AM EST, 11/08/2024 (MT Newswires) -- CompoSecure ( CMPO ) reported Q3 adjusted net income Friday of $0.27 per diluted share, up from $0.24 a year earlier.

Analysts polled by Capital IQ expected $0.29.

Net sales for the quarter ended Sept. 30 were $107.1 million, up from $96.9 million a year earlier.

Analysts surveyed by Capital IQ expected $105.5 million.

For the full-year 2024, the company said it now expects net sales in the range of $418 million to $424 million, compared with its prior outlook of $418 million to $428 million. Analysts polled by Capital IQ expect $425.6 million.

Shares of the company were down more than 5% in recent Friday premarket activity.

Price: 14.76, Change: -0.87, Percent Change: -5.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
Dec 9, 2024
By Mariam Sunny Dec 9 (Reuters) - AbbVie's ( ABBV ) experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out daily tasks such as eating and walking, months after the drugmaker disclosed its success in a separate study. The late-stage study tested the safety and efficacy of flexible doses of the once-daily drug, tavapadon,...
Trump aides contact Google, Meta, Snap over online drug sales, The Information reports
Trump aides contact Google, Meta, Snap over online drug sales, The Information reports
Dec 9, 2024
(Reuters) -President-elect Donald Trump's transition team has invited five major tech companies, including Google, Microsoft and Meta Platforms to a meeting in mid-December about dealing with online sales of drugs, The Information reported on Sunday. A representative for Jim Carroll, the drug czar during Trump's first term, and Trump's transition team emailed staffers from the three tech giants on Thursday,...
Netflix Unusual Options Activity For December 09
Netflix Unusual Options Activity For December 09
Dec 9, 2024
Investors with a lot of money to spend have taken a bearish stance on Netflix ( NFLX ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Editas Medicine Shares Jump as Potential Gene Therapy for Sickle Cell Disease Found to Be 'Well-Tolerated'
Editas Medicine Shares Jump as Potential Gene Therapy for Sickle Cell Disease Found to Be 'Well-Tolerated'
Dec 9, 2024
12:25 PM EST, 12/09/2024 (MT Newswires) -- Editas Medicine ( EDIT ) shares were up almost 7% in recent trading Monday after the company said that its renizgamglogene autogedtemcel, or reni-cel, therapy continued to be well-tolerated in sickle cell disease patients. Updated data from the company's clinical trial showed that all 28 subjects with severe sickle cell disease showed a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved